Neumora Therapeutics Inc’s recently made public that its Director Burow Kristina acquired Company’s shares for reported $5.0 million on Oct 27 ’25. In the deal valued at $2.61 per share,1,915,700 shares were bought. As a result of this transaction, Burow Kristina now holds 6,046,907 shares worth roughly $18.26 million.
Then, ARCH Venture Partners XII, LLC bought 1,915,700 shares, generating $4,999,977 in total proceeds. Upon buying the shares at $2.61, the 10% Owner now owns 6,046,907 shares.
Before that, ARCH Venture Partners X, LLC bought 1,915,700 shares. Neumora Therapeutics Inc shares valued at $4,999,977 were divested by the 10% Owner at a price of $2.61 per share. As a result of the transaction, ARCH Venture Partners X, LLC now holds 6,046,907 shares, worth roughly $18.26 million.
Guggenheim upgraded its Neumora Therapeutics Inc [NMRA] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in mid September from “a Neutral” to “an Underweight”. BofA Securities also remained covering NMRA and has decreased its forecast on April 02, 2025 with a “an Underperform” recommendation from previously “Buy” rating. William Blair revised its rating on March 10, 2025. It rated NMRA as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of NMRA
On Friday, Neumora Therapeutics Inc [NASDAQ:NMRA] saw its stock jump 3.07% to $3.02. Over the last five days, the stock has gained 14.83%. Neumora Therapeutics Inc shares have fallen nearly -74.25% since the year began. Nevertheless, the stocks have fallen -71.51% over the past one year. While a 52-week high of $14.09 was reached on 10/31/25, a 52-week low of $0.61 was recorded on 05/14/25.
Levels Of Support And Resistance For NMRA Stock
The 24-hour chart illustrates a support level at 2.81, which if violated will result in even more drops to 2.60. On the upside, there is a resistance level at 3.24. A further resistance level may holdings at 3.46.
How much short interest is there in Neumora Therapeutics Inc?
A steep rise in short interest was recorded in Neumora Therapeutics Inc stocks on 2025-10-15, growing by 0.37 million shares to a total of 6.79 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 6.42 million shares. There was a rise of 5.46%, which implies that there is a positive sentiment for the stock.
